In November 2026, Manulife published its third-quarter shareholder report, identifying a Canadian group long-term disability study on claim termination as the main driver of a C$39 million decrease in pre-tax fulfilment cash flows from mortality and morbidity assumption updates. The report was released on 4 November for the quarter ended 30 September. The figure combines several changes: it is not a standalone measure of Canadian disability reserves, claims paid or savings available to employers.

Why the end of a claim matters

Disability financing depends on both the number of people who begin receiving benefits and how long they remain eligible. Two plans can see similar rates of new claims and develop very different costs if one has more claims that remain open for years. An assumption about the end of a claim therefore affects the expected stream of future payments on claims already in force. It is a separate question from how many employees will become disabled next year.

A claim ending is also not necessarily evidence that an employee has recovered or returned to work. The underlying reason can be a recovery, the expiry of a contractual benefit period or another event under the policy. The report identifies the subject of the actuarial study but does not provide a breakdown that would support attributing the C$39 million movement to any particular employee outcome. Readers should also keep the Canadian group disability study separate from the company’s review of US long-term care liabilities.

What to ask at the next renewal

Start with a claims review that separates incidence, duration and the amount paid. Ask for observations grouped by how long the claim has been open, using consistent definitions and sufficiently large groups. Where permitted and useful, distinguish confirmed returns to work from other reasons a claim ceased. Compare the experience with the assumptions behind the quotation. If a portfolio is too small to support a credible estimate of its own, ask what broader evidence the insurer uses and where that population differs from yours.

A multinational employer should also check whether its country reports use the same language for different measures. A claim may close in an administrator’s system even while another insurer, a public programme or the employer continues paying benefits. Before comparing subsidiaries, agree whether the measure is the end of insurer payments, a sustained return to work or an administrative closure. Each answers a different question and calls for a different response.

What a captive board should test

Where a captive retains disability exposure, its board can ask the actuary to show how slower claim terminations would change expected payments, funding needs and results under the actual reinsurance terms. The analysis should identify which risks are retained and which transfer to another party, including any limitations or attachment points. A model that performs well for short claims may still misstate the exposure in the longest claims, where changes in duration can matter most.

Independent non-executive directors should ask for a reconciliation between actual claim exits and the assumptions used in the captive’s reserves, and challenge whether thin experience warrants relying on a broader benchmark. They should also request a scenario in which rehabilitation and returns to work take longer than planned, so management can show how that would affect funding and liquidity.

The practical takeaway is to ask for an explanation of changes in disability costs before negotiating from the headline alone. A reserve update can help identify what to investigate, but renewal decisions need the experience of the covered workforce and the terms of the policy. Employers should track service and recovery outcomes alongside financial measures, keeping medical details confidential and using aggregate information for governance. That makes it possible to test whether support is helping employees while maintaining a clear view of the liability the employer or captive has agreed to fund.

Sources

Manulife shareholder report, filed with SEC | Quarter ended 30 Sep 2026 – Manulife updates Canadian group disability claim assumptions